Clinical Trials Browser

Interventional × Metformin × 30 days × Clear all

NCT02365597 2026-04-13

An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer

Phase 2 Active not recruiting

239 enrolled 32 charts 2 FDA

Urothelial Cancer

NCT02581137 2026-04-13

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Phase 2 Active not recruiting

26 enrolled 10 charts

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

NCT05966792 2026-04-13

SGLT2 Inhibitors in Treating Patients With PCOS

Phase NA Completed

Polycystic Ovary Syndrome

NCT05445791 2026-04-09

METLUNG

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07226453 2026-04-08

PNOC041

Phase 2 Not yet recruiting

Posterior Fossa Ependymal Tumor

NCT02437656 2026-03-31

METCAP

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

NCT05036226 2026-03-30

COAST

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

NCT02122185 2026-03-27

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

111 enrolled 15 charts

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms, Pleural Effusion, Malignant

NCT06899061 2026-03-27

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Phase 1 Active not recruiting

Advanced Solid Malignancies